Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

ILC1-like cells can independently cause alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Cyclosporine effectively treated a woman's stubborn skin condition.

New therapies are being developed that target integrin pathways to treat various diseases.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Influencers impact medical communication both positively and negatively.